Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Cardiac Manifestations of Coronavirus (COVID-19)

Indranill Basu-Ray  1 , Nureddin k. Almaddah  2 , Sarosh Vaqar, Michael P. Soos  3
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Cardiac Manifestations of Coronavirus (COVID-19)

Indranill Basu-Ray et al.
Free Books & Documents

Excerpt

Coronaviruses are a large family of single-stranded positive-sense, enveloped RNA viruses that can infect many animal species. Human coronaviruses can be divided based on their pathogenicity. The types with high pathogenicity include SARS-CoV, MERS-CoV, and the current novel SARS-CoV2 viruses.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were first identified in December 2019 and termed coronavirus disease 2019 (COVID-19). By March 2020, it was declared a global pandemic by the World Health Organization (WHO).

Although primarily a respiratory disease, COVID-19 has been associated with many cardiac complications. Cardiac injury is recognized as one of the most frequent complications of the disease. Long-term cardiac complications following COVID-19 include ischemic heart disease, heart failure, arrhythmias, and myocarditis.

Studies have consistently shown that underlying cardiovascular disease in patients with COVID-19 and/or the development of acute cardiac injury due to COVID-19 illness is associated with significantly worse outcomes. This activity reviews the clinical manifestations of cardiac complications related to COVID-19 infections and outlines their recommended evaluation as well as their treatment.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Indranill Basu-Ray declares no relevant financial relationships with ineligible companies.

Disclosure: Nureddin Almaddah declares no relevant financial relationships with ineligible companies.

Disclosure: Sarosh Vaqar declares no relevant financial relationships with ineligible companies.

Disclosure: Michael Soos declares no relevant financial relationships with ineligible companies.

References

    1. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64. - PMC - PubMed
    1. Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, Sefen JAN, Sidhu P, Atallah B, El-Lababidi R, Al-Qahtani M. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob. 2021 May 18;20(1):35. - PMC - PubMed
    1. Srinivasan A, Wong F, Couch LS, Wang BX. Cardiac Complications of COVID-19 in Low-Risk Patients. Viruses. 2022 Jun 17;14(6) - PMC - PubMed
    1. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. - PMC - PubMed
    1. Zapor M. Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients. Viruses. 2020 Dec 03;12(12) - PMC - PubMed

Publication types

LinkOut - more resources